When Ozempic And Wegovy Fail To Work- Why GLP-1 Drugs Aren’t The Magic Bullet For Everyone
Ozempic and Wegovy have received a lot of publicity as revolutionizing treatment options for obesity. Both medications form a class of GLP-1 receptor agonists, which mimic a hormone in the body called glucagon-like peptide-1 and are involved in the regulation of appetite and blood sugar. Indeed, in initial clinical studies, the majority of those on the drugs lost 15% to 22% of body weight, hence much optimism. For most patients, these medications are underwhelming for about 20% of patients due to minimal weight loss or other challenges.
Take a closer look at why the weight loss drugs may not work for everyone, together with what options exist when they don't deliver the expected outcomes.
While GLP-1 receptor agonists have produced phenomenal responses in a majority of patients, it remains a reality that these drugs work differently for different people. Here's why:
1. Genetic and Hormonal Variability
Weight loss medications interact with complex systems in the body that differ from person to person. Genetics, hormones, and individual brain responses to energy regulation play significant roles in determining how a person responds to drugs like Ozempic and Wegovy.
2. Underlying Medical Conditions
Other conditions, such as sleep apnea, may be prevalent and prevent or delay the achievement of weight loss goals. Prescription drugs like antidepressants, steroids, or contraceptives are other medications that can nullify weight loss medication benefits.
3. Unrealistic Expectations
Often, they come to these medications with enormous hopes; expecting the promised rapid and dramatic weight loss. Progress creates disappointment if it has not stalled. In patients who rigidly follow recommended lifestyle modifications, frustration and disappointment are most common.
For most patients, the effectiveness of GLP-1 receptor agonists is evident within a few weeks of treatment. Weight loss typically begins within a few weeks of initiating therapy and tends to increase with dosage. However, some patients respond very little, if at all, despite strict adherence to their regimen.
For nonresponders, this can feel like a dead end. However, understanding the unique complexities of obesity is essential. This condition stems from brain dysfunction, and the pathways that contribute to weight regulation differ among individuals.
When Ozempic or Wegovy doesn’t yield desired results, there are still many paths to explore:
For example, some patients who don't respond well to one GLP-1 receptor agonist might find success with another drug in the same class. Newer medications, such as Zepbound, target other hormone pathways and seem promising even for those not responsive to earlier drugs.
While there is much to say about newer drugs, older treatments can still be useful and work for some patients. One can also seek the help of a medical provider specializing in obesity treatments in order to identify the best alternatives.
Diet, exercise, sleep, and stress management continue to be integral components of any weight loss program. New changes may be small but can make an enormous difference in one's health and success.
It is a complex disorder, and most patients should receive a multidisciplinary treatment. Collaboration with an obesity-aware doctor may mean access to tailored treatment plans, ranging from psychological support all the way to metabolic testing, and many others.
For others, side effects like nausea, vomiting, or diarrhea hinder them from continuing with these drugs. These symptoms often reduce as the body becomes accustomed, but for some, they might be severe enough to stop treatment altogether. In those instances, alternative drugs or procedures become vital to find.
Another largely unexplored area relates to GLP-1 drugs' long-term effects on the brain's regulation of hunger and satiety. Although GLP-1 drugs suppress appetite and can lead to effective weight loss, emerging research suggests that they may also affect brain reward mechanisms, changing the way patients experience foods.
This aspect could prove of paramount significance in the future treatment of obesity. Perhaps GLP-1 receptor agonists do indeed affect and rewire the brain's reward pathways and will thus provide sustained benefits beyond discontinuation. However, more research is required to understand this phenomenon fully.
While for many, Ozempic and Wegovy have revolutionized obesity treatment, these are certainly not a one size fits all. Nonresponders need not lose hope- alternative strategies and medications abound. A consultation with an obesity expert healthcare provider is essential to put together a comprehensive, tailored treatment plan.
The route toward effective weight loss may be challenging, but with the evolution of obesity medicine and a better understanding of individual needs, there is a path forward for everyone.
Credits: iStock
Delhi's air quality remained in "very poor" category, and the AQI stood at 342 at 8am, as per the Central Pollution Control Board. The 24-hour average AQI was logged at 412 under the "severe" category on Tuesday evening when Delhi's quality peaked to record the fourth severe air day in the month of December. With the air quality levels remaining continuously in the "very poor" category, Delhi's Chief Minister Rekha Gupta held a pollution review meet.
A review meeting was held to discuss the rising air pollution levels in Delhi on Monday at the Delhi Secretariat. The meeting was attended by the officials from various departments, which also included the Public Works Department (PWD), Transport, Delhi Pollution Control Committee (DPCC), Environment, and others.
Post meeting, Delhi Environment Minister Manjinder Singh Sirsa said that the CM sought responses from multiple departments to discuss various aspects of pollution in the national capital. Sirsa also confirmed that a follow-up meeting will be scheduled on Thursday to continue the discussions on various steps that should be taken to bring down the levels of Delhi's AQI.
On Sunday, a day before the meeting was held, Delhi's CM spoke on relying on public transport as a solution to Delhi's pollution. She said that the government aims to make the metro network "so comprehensive that people do not need to rely on private vehicles even for last-mile connectivity”.
An analysis by the Global Burden of Disease (GBD) 2023 found that air pollution is city's single largest health risk. The deaths rose from 15,786 in 2018 to 17,188 in 2023.
Another study published in Scientific Reports, a five-year study titled Respiratory Deposition of Particulate Matter in Delhi: A Five-Year Assessment of Exposure Patterns and Health Risks tracked how particulate matter settles inside the respiratory system and found that men's exposure can be up to 1.4 times higher, especially while walking or commuting. The study noted that men on average spend more time outdoors while working, commuting, or walking in traffic-heavy areas. This leads to an increase in exposure.
A different study published in Frontiers in Public Health, explored the data of 2,96,078 women and girls between the age of 16 to 55 years in Taiwan and correlated it with the long-term air pollution data between 2000 and 2013. None of these women had any history of dysmenorrhea before the survey had began.
Read: Is Delhi's Toxic Air Making Your Period Cramps More Painful? Here's What Study Says
Furthermore, a study published in Nature Communication notes that after four hours of exposure to particulate matter, it was found that people's ability to perform routine tasks and interpret emotions were highly impacted.
If Delhi is able to cut its local pollution by 50 per cent, the pollution too could drop by 50 per cent. The emission should happen across the airshed. However, the focus should be for a long-term action on the source of emission and not short-term optics like cloud seeding, smog towers, water sprinkling or air purifiers.
In fact, as per a study published in Sustainability (MDPI), an open access journal, which mapped Delhi's air quality between 1990 to 2022 and found that transports emit around 10 to 30% of pollution, whereas agricultural residue burning, which is a seasonal source of pollution leads to less than 3% of pollution, whereas firecrackers, another seasonal source, leads to less than 1% of pollution.
Credits: iStock
Do you feel an awful soar in your throat? Have you noticed that anyone you speak to are also complaining of the same symptoms? All of them, and you, seem tired, have a sore throat and no energy for days and weeks to follow. This might be what people are called "mystery disease" or the "mystery throat virus". However, this is actually the adenovirus.
Most patients with bad throat, explain experts have adenovirus, which is a common virus that spreads throughout the year. However, unlike the flu and COVID, which now have their own prescribed medicines, adenovirus has none.
Read: This Mysterious New Virus Could Spread Faster Than Covid-19 And Flu
Adenovirus is a virus that has more than 60 different strains, which is why it is able to cause a variety of symptoms. Adenovirus refers to a group of common viruses that usually trigger cold- or flu-like illness. It spreads easily because it is far more resilient than many other viruses. Ordinary soap, water, and standard disinfectants do not reliably destroy it, allowing it to persist in the environment. As a result, infections often cluster in places where people spend time close together, such as daycares and military barracks. The virus spreads through the respiratory tract, can be shed in stool, and can survive for some time on contaminated surfaces, according to the CDC.
The reason for its spread right now is due to the surge of flu cases in the southern hemisphere which has influenced the outbreaks in the northern hemisphere. Another reason is the lower flu vaccinate rates, which has now made a large number of population more vulnerable to infections, overall, including adenovirus.
While a lot of the symptoms mimics of those in flu or COVID, including shortness of breath, a sore throat and or a runny nose. However, there are certain unique symptoms of adenovirus that include:
Other rare symptoms could also include impact on your bladder or nervous system. As viruses in your bladder can also cause urinary tract infections, and the same virus in your nervous system can cause condition that can affect your brain. These conditions also include encephalitis and meningitis.
Read: Unique Symptoms Of Mysterious Adenovirus And How Long Infection Now Last
What makes this virus unique is that it can spread through easily. Adenovirus is highly contagious. It can spread from one person to another through shaking hands, kissing, or even hugging. The virus could also spread through sneezing, coughing, and if by any other means respiratory droplets transfers to other person in air. It can also spread by touching contaminated surface, and you can get the virus by touching your eyes, nose, or mouths if you do not wash your hands.
The virus can also spread through stool of an infected person. For instance, you can be infected while changing your baby's diaper. It can also spread through unchlorinated water, and a person can be infected with the virus if he or she swims in a pool without adequate chlorine.
Adenoviruses are resistant to many common disinfectants. Therefore, they can remain infectious on surfaces for a long time.
If you are generally healthy, and feel a little down, but do not have shortness of breathe or a high fever, you are safe to go, with supportive care at home. However, pay close attention to those who are already on medical attention, or those who are immunocompromised, or are infants.
If you are sick, have a high fever, and experiencing shortness of breath, it is best to consult your doctor. However, do not show up to your doctor's office, call first.
Credits: Wikimedia Commons
Ben Sasse, former Senator, on Tuesday shared that he has been diagnosed with pancreatic cancer. His diagnosis came at Stage 4.
The former two-term senator, 53, revealed this in a social media or X, message: “This is a hard note to write, but since many of you have already sensed something, I’ll get straight to it: Last week I was diagnosed with metastasized, stage-four pancreatic cancer, and I am going to die.”
Also Read: 2 Dead, 21 Injured After Pennsylvania Nursing Home Catches Fire
Stage 4 cancers are terminal and his terminal diagnosis was "hard for someone wired to work and build, but harder still as a husband and a dad," he said.
Stage 4 cancers are terminal because the cancer has metastasized, which means it has spread from its original site or the primary tumor to distant organs and tissues. This makes it extremely difficult to cure with localized treatments like surgery or radiation.
However, the American Oncology Institute does note that stage 4 cancer always does not have to be terminal, especially with breakthrough treatment options like targeted therapy, immunotherapy, or precision medicine. There are now also advanced surgical techniques that use minimal invasion procedures.
Also Read: Ben Sasse Diagnosed With Stage 4 Pancreatic Cancer: What We Know About His Diagnosis
According to the American Cancer Society, pancreatic cancer makes up about 3 percent of all cancers in the United States but accounts for roughly 8 percent of cancer-related deaths. Most patients are diagnosed at Stage 4, and the disease is widely regarded as largely incurable. Prostate cancer, by contrast, is the second most common cancer among men, and the majority of those diagnosed do not die from it. The five-year relative survival rate for non-metastasized prostate cancer is 97.9 percent, dropping to about 38 percent once it spreads. These figures highlight how early detection and effective treatment options make prostate cancer far more survivable than pancreatic cancer.
While treatments including chemotherapy, radiation, and in rare situations surgery are available, stage-four pancreatic cancer is still considered largely incurable. The absence of effective early screening contributes to delayed diagnosis, and although a small number of patients, such as Ruth Bader Ginsburg, have lived longer following surgery, these cases are rare. Well-known individuals including Alex Trebek and Aretha Franklin also battled the disease, which remains one of the deadliest cancers in the United States.
Former senator and former University of Florida president Ben Sasse announced on Tuesday, Dec. 23, that he has been diagnosed with terminal stage 4 cancer, as per CNN News.
In the deeply personal message, the former Republican lawmaker from Nebraska described the diagnosis as a “death sentence,” while expressing appreciation for the steady support of his family and close friends.
“I’m fortunate to have incredible siblings and half a dozen friends who are truly like brothers to me. As one of them said, ‘Yes, you’re on the clock, but all of us are.’ Death is a cruel thief, and none of us escape it,” he added.
© 2024 Bennett, Coleman & Company Limited